Trial Profile
An Open-label, Fixed-sequence, Phase 1 Study of the Effect of CYP3A4 Inhibition by Itraconazole on the Pharmacokinetics of BIIB074 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Vixotrigine (Primary) ; Itraconazole
- Indications Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Biogen
- 29 Mar 2021 Results of Population PK model analysis from 12 clinical studies: SCB107718, SCB107727, SCB113210, SCB113210, 802HV101, 802HV102, 802HV104, 802HV105, 802HV106, 802HV107, 1014802/202, 1014802/201 and 1014802/205 published in the European Journal of Drug Metabolism and Pharmacokinetics
- 01 Sep 2017 Results published in the Clinical Pharmacology in Drug Development: 2017 Annual Meeting of the American College of Clinical Pharmacology.
- 07 Jun 2016 Status changed from recruiting to completed.